B01J47/02

METHOD FOR RECOVERING ACTIVE METAL OF LITHIUM SECONDARY BATTERY
20230369670 · 2023-11-16 ·

In a method for recovering active metals of a lithium secondary battery according to an embodiment, a cathode active material mixture is collected from the cathode of the lithium secondary battery, the cathode active material mixture is reduced by a reducing reaction to prepare a preliminary precursor mixture, an aqueous lithium precursor solution is formed from the preliminary precursor mixture, and an aluminum-containing material is removed from the aqueous lithium precursor solution with an aluminum removing resin.

METHOD FOR RECOVERING ACTIVE METAL OF LITHIUM SECONDARY BATTERY
20230369670 · 2023-11-16 ·

In a method for recovering active metals of a lithium secondary battery according to an embodiment, a cathode active material mixture is collected from the cathode of the lithium secondary battery, the cathode active material mixture is reduced by a reducing reaction to prepare a preliminary precursor mixture, an aqueous lithium precursor solution is formed from the preliminary precursor mixture, and an aluminum-containing material is removed from the aqueous lithium precursor solution with an aluminum removing resin.

THERAPEUTIC COMPOSITIONS FOR VIRAL-ASSOCIATED DISEASE STATES AND METHODS OF MAKING AND USING SAME

A method comprising obtaining a bodily fluid from a subject; contacting the bodily fluid with an adsorbent material comprising a synthetic carbon particle (SCP) to produce a first filtrate having a level of disease mediators (y); contacting the first filtrate with an adsorbent material comprising the SCP and an anion exchange resin where the ratio of SCP to anion exchange resin is in a range from about 0.1:100 to 100:0.1 to produce a second filtrate; contacting the second filtrate with an adsorbent material comprising the SCP and a cation exchange resin where the ratio of SCP to cation exchange resin is in a range from about 0.1:100 to 100:0.1 to produce a third filtrate.

THERAPEUTIC COMPOSITIONS FOR VIRAL-ASSOCIATED DISEASE STATES AND METHODS OF MAKING AND USING SAME

A method comprising obtaining a bodily fluid from a subject; contacting the bodily fluid with an adsorbent material comprising a synthetic carbon particle (SCP) to produce a first filtrate having a level of disease mediators (y); contacting the first filtrate with an adsorbent material comprising the SCP and an anion exchange resin where the ratio of SCP to anion exchange resin is in a range from about 0.1:100 to 100:0.1 to produce a second filtrate; contacting the second filtrate with an adsorbent material comprising the SCP and a cation exchange resin where the ratio of SCP to cation exchange resin is in a range from about 0.1:100 to 100:0.1 to produce a third filtrate.

Ion exchange chromatography column, method, and system thereof

An ion exchange chromatographic packing material is described that includes support resin particles and a copolymer grafted to the support resin particles. The copolymer includes polymerized functional monomers such as a first ion exchange group monomer and a second ion exchange group monomer. At a first pH, the first ion exchange group monomer is configured to have a first charge at a first pH, and the second ion exchange group monomer is configured to have a net neutral charge. At a second pH, the first ion exchange group monomer is configured to have the first charge at a second pH, and the second ion exchange group monomer is configured to have a second charge at the second pH where the first charge and second charge both have a same polarity.

Ion exchange chromatography column, method, and system thereof

An ion exchange chromatographic packing material is described that includes support resin particles and a copolymer grafted to the support resin particles. The copolymer includes polymerized functional monomers such as a first ion exchange group monomer and a second ion exchange group monomer. At a first pH, the first ion exchange group monomer is configured to have a first charge at a first pH, and the second ion exchange group monomer is configured to have a net neutral charge. At a second pH, the first ion exchange group monomer is configured to have the first charge at a second pH, and the second ion exchange group monomer is configured to have a second charge at the second pH where the first charge and second charge both have a same polarity.

Sorbent for a dialysis device and dialysis system

The invention relates to a sorbent for removing metabolic waste products from a dialysis liquid, the sorbent comprising a soluble source of sodium ions. The sorbent comprises an ion exchange system which converts urea to ammonium ions and which is configured to exchange ammonium ions for predominantly hydrogen ions and to exchange Ca, Mg, and K for predominantly sodium ions. The soluble source of sodium ions overcomes an initial drop in sodium concentration in regenerated dialysate. When used in conjunction with an infusion system configured to utilise exchange of Ca, Mg and K for sodium during dialysate regeneration a desired sodium ion concentration can be maintained.

Process For Purifying Potassium Chloride
20220259058 · 2022-08-18 · ·

A process for the preparation of purified potassium chloride comprises the at least partial removal of one or more class 1 heavy metal impurity (lead, arsenic, cadmium and/or mercury) from potassium chloride process liquor by an ion exchange step. The process uses an ion exchange resin and achieves high levels of purity and is compatible with high flow rates. A recrystallisation step (e.g. a cooling crystallization step) may be employed subsequent to the ion exchange step.

Process For Purifying Potassium Chloride
20220259058 · 2022-08-18 · ·

A process for the preparation of purified potassium chloride comprises the at least partial removal of one or more class 1 heavy metal impurity (lead, arsenic, cadmium and/or mercury) from potassium chloride process liquor by an ion exchange step. The process uses an ion exchange resin and achieves high levels of purity and is compatible with high flow rates. A recrystallisation step (e.g. a cooling crystallization step) may be employed subsequent to the ion exchange step.

METHOD FOR PRODUCING SILICON-CONTAINING POLYMER COMPOSITION
20220297109 · 2022-09-22 · ·

A purification method for a silicon-containing polymer composition capable of reducing metal impurities in a silicon-containing polymer composition to be treated, while suppressing the weight average molecular weight change before and after the treatment, by treating the silicon-containing polymer composition containing the metal impurities with an ion exchange resin having a specific structure; a silicon-containing polymer composition; and a method for producing a semiconductor device. A purification method for a silicon-containing polymer composition reduced in weight average molecular weight change before and after treatment, said method being treating a silicon-containing polymer composition to be treated containing an organic solvent with an gel-type cation exchange resin. The weight average molecular weight change before and after the treatment is 70 or less. The ion exchange resin preferably has a strongly acidic functional group. The total residual amount of 24 metal elements after the ion exchange treatment is 1 ppb or less.